Blockchain Registration Transaction Record

20Slash20's Eye Drink to Shine at Moody Capital's 2026 Conference

20Slash20 presents The Eye Drink at Moody Capital's 2026 conference. Discover the first functional beverage for screen-induced eye strain, backed by AREDS 2 nutrients. Learn more.

This news matters because it highlights a novel solution to a widespread modern problem: the detrimental effects of blue light and screen time on eye health. With millions of people spending hours daily on digital devices, products like The Eye Drink offer a convenient, scientifically backed approach to preventive eye care. The conference participation not only provides exposure for 20Slash20 but also signals to investors and consumers that functional beverages targeting specific health concerns are an emerging trend with significant market potential. For readers, this could mean new options to protect their vision in a screen-dominated world, and it underscores the importance of proactive health measures.